Gyre Therapeutics Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Gyre Therapeutics Inc
Access all reports
Gyre Therapeutics Inc., formerly known as Catalyst Biosciences, Inc., is a biopharmaceutical company engaged in the development and commercialization of therapies for organ fibrosis and inflammatory diseases. The company's main focus is on the development of Hydronidone (F351), a therapeutic aimed at treating Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis), previously known as Nonalcoholic Steatohepatitis (NASH). The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Key slides for Gyre Therapeutics Inc
Investor Presentation
Gyre Therapeutics Inc
Investor Presentation
Gyre Therapeutics Inc
Latest articles
Amazon's Most Notable Acquisitions Since Inception
Explore Amazon's most impactful acquisitions, from IMDb and Zappos to Whole Foods and MGM, and how these have diversified its business.
13 May 2024
Adidas vs Puma: The Story of the Dassler Brothers
An in-depth article outlining the story of the Dassler brothers, their feud with one another, and the history of Puma and Adidas.
10 May 2024
Satya Nadella: The Architect of Microsoft's Resurgence
The journey of Satya Nadella, from his early life in India to reshaping Microsoft as its CEO, emphasizing cloud computing and inclusive leadership.
10 May 2024
Ticker symbol
Country
🇺🇸 United States